3,3',4'-trihydroxyflavone has been researched along with pd 98059 in 1 studies
Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (pd 98059) | Trials (pd 98059) | Recent Studies (post-2010) (pd 98059) |
---|---|---|---|---|---|
39 | 0 | 22 | 4,939 | 3 | 1,001 |
Protein | Taxonomy | 3,3',4'-trihydroxyflavone (IC50) | pd 98059 (IC50) |
---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 2.8 | |
Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 6.3 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 2.8 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 2.8 | |
Dual specificity mitogen-activated protein kinase kinase 2 | Rattus norvegicus (Norway rat) | 4.2 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Rattus norvegicus (Norway rat) | 4.2 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kedikaetswe, A; Lim, NR; May, CN; Ng, DC; Thomas, CJ; Woodman, OL; Yeap, YY | 1 |
1 other study(ies) available for 3,3',4'-trihydroxyflavone and pd 98059
Article | Year |
---|---|
Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
Topics: Animals; Cardiotonic Agents; Chromones; Drug Therapy, Combination; Female; Flavonoids; Flavonols; MAP Kinase Signaling System; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Prodrugs; Proto-Oncogene Proteins c-akt; Rats; Sheep; Signal Transduction | 2015 |